Advertisement
Home »

Baseline Body Surface Area and Itch Severity Define Response to Baricitinib in Patients with Moderate-to-Severe Atopic Dermatitis at Week 16.

Jun 19, 2023

ABOUT THE EXPERTS

  • Jacob P Thyssen

    Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark. jacob.pontoppidan.thyssen@region.dk.

    Marjolein de Bruin-Weller

    Department of Dermatology and Allergology, National Expertise Center of Atopic Dermatitis, University Medical Center Utrecht, Utrecht, The Netherlands.

    Antonio Costanzo

    Dermatology, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.

    Dermatology, Humanitas Research Hospital, Rozzano, Milan, Italy.

    Susanne Grond

    Eli Lilly and Company, Indianapolis, IN, USA.

    Christopher Schuster

    Eli Lilly and Company, Indianapolis, IN, USA.

    Department of Dermatology, Medical University of Vienna, Vienna, Austria.

    Chunyuan Liu

    Tigermed-BDM Inc, Somerset, NJ, USA.

    Maria Jose Rueda

    Eli Lilly and Company, Indianapolis, IN, USA.

    Yun-Fei Chen

    Eli Lilly and Company, Indianapolis, IN, USA.

    Andreas Pinter

    Department of Dermatology, Venereology and Allergology, University Hospital Frankfurt, Frankfurt am Main, Germany.

    Thomas Bieber

    Department of Dermatology and Allergy, University Hospital, Bonn, Germany.

    Christine Kühne-Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement